Balyasny Asset Management LLC Legend Biotech Corp Call Options Transaction History
Balyasny Asset Management LLC
- $63.6 Billion
- Q4 2024
Call Options
1 transactions
Others Institutions Holding LEGN
# of Institutions
231Shares Held
86MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$291 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$264 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$232 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$222 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$221 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.49B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...